Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Clin Otolaryngol ; 43(5): 1226-1234, 2018 10.
Article in English | MEDLINE | ID: mdl-29733111

ABSTRACT

BACKGROUND: The number of potential options for rehabilitation of patients with conductive or mixed hearing loss is continually expanding. To be able to inform patients and other stakeholders, there is a need to identify and develop patient-centred outcomes for treatment of hearing loss. OBJECTIVE OF REVIEW: To identify outcome measures in the physical core area used when reporting the outcome after treatment of conductive and mixed hearing loss in adult patients. TYPE OF REVIEW: Systematic review. SEARCH STRATEGY: Systematic review of the literature related to reported physical outcome measures after treatment of mixed or conductive hearing loss without restrictions regarding type of intervention, treatment or device. EVALUATION METHOD: Any measure reporting the physical outcome after treatment or intervention of mixed or conductive hearing loss was sought and categorised. The physical outcome measures that had been extracted were then grouped into domains. RESULTS: The literature search resulted in the identification of 1434 studies, of which 153 were selected for inclusion in the review. The majority (57%) of papers reported results from middle ear surgery, with the remainder reporting results from either bone conduction hearing devices or middle ear implants. Outcomes related to complications were categorised into 17 domains, whereas outcomes related to treatment success was categorised into 22 domains. CONCLUSIONS: The importance of these domains to patients and other stakeholders needs to be further explored in order to establish which of these domains are most relevant to interventions for conductive or mixed hearing loss. This will allow us to then assess which outcome measures are most suitable for inclusion in the core set.


Subject(s)
Hearing Loss, Conductive/therapy , Hearing Loss, Mixed Conductive-Sensorineural/therapy , Humans , Outcome Assessment, Health Care
2.
IEEE Trans Neural Syst Rehabil Eng ; 25(8): 1353-1362, 2017 08.
Article in English | MEDLINE | ID: mdl-27831887

ABSTRACT

This study models induced electric fields, and their gradient, produced by pulsatile current stimulation of submillimeter inductors for cochlear implantation. Using finite-element analysis, the lower chamber of the cochlea, scala tympani, is modeled as a cylindrical structure filled with perilymph bounded by tissue, bone, and cochlear neural elements. Single inductors as well as an array of inductors are modeled. The coil strength (~100 nH) and excitation parameters (peak current of 1-5 A, voltages of 16-20 V) are based on a formative feasibility study conducted by our group. In that study, intracochlear micromagnetic stimulation achieved auditory activation as measured through the auditory brainstem response in a feline model. With respect to the finite element simulations, axial symmetry of the inductor geometry is exploited to improve computation time. It is verified that the inductor coil orientation greatly affects the strength of the induced electric field and thereby the ability to affect the transmembrane potential of nearby neural elements. Furthermore, upon comparing an array of micro-inductors with a typical multi-site electrode array, magnetically excited arrays retain greater focus in terms of the gradient of induced electric fields. Once combined with further in vivo analysis, this modeling study may enable further exploration of the mechanism of magnetically induced, and focused neural stimulation.


Subject(s)
Cochlea/physiology , Cochlea/radiation effects , Electric Stimulation Therapy/methods , Evoked Potentials, Auditory, Brain Stem/physiology , Evoked Potentials, Auditory, Brain Stem/radiation effects , Models, Biological , Computer Simulation , Dose-Response Relationship, Radiation , Finite Element Analysis , Humans , Magnetic Field Therapy/methods , Magnetic Fields , Radiation Dosage
4.
Eur Arch Otorhinolaryngol ; 271(7): 1917-21, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24030853

ABSTRACT

Congenital aural atresia (CAA) poses significant challenges to surgical remediation. Both bone anchored hearing aids (BAHA) and the Vibrant Soundbridge (VSB) have been considered as alternatives or adjuncts to conventional atresiaplasty. A consensus statement on VSB implantation in children and adolescents recommended against implantation when the Jahrsdoerfer score was less than 8. More recent publications suggest that patients with Jahrsdoerfer scores between three and seven may benefit from VSB implantation. The purpose of this study was to further investigate the outcomes of VSB implantation in CAA. The study was a multi-center, retrospective review. A retrospective review of data (patient's demographic, clinical, implant and audiological information) from four collaborating centers that have performed VSB implantation in CAA was performed. Outcomes based on severity of the atresia using the Jahrsdoerfer and Yellon-Branstetter scoring systems were also evaluated. Data from 28 patients from the four centers revealed no iatrogenic facial nerve injuries or change in bone thresholds. Post-operative speech threshold and speech recognition was, respectively, 39 dB and 94%. Jahrsdoerfer and Yellon scores ranged from 4 to 9 and 4 to 12, respectively. The scores did not correlate to or predict outcomes. Three individual elements of the scores did correlate to initial, but not long-term outcomes. Atresiaplasty and BAHA in the management of CAA are not complete solutions. VSB may offer an alternative in these surgically complex patients for achieving amplification, though better metrics for patient selection need to be developed. LEVEL OF EVIDENCE : IV.


Subject(s)
Congenital Abnormalities/therapy , Ear/abnormalities , Hearing Aids , Ossicular Prosthesis , Adolescent , Adult , Aged , Auditory Threshold , Child , Female , Humans , Male , Middle Aged , Retrospective Studies , Severity of Illness Index , Speech Perception , Treatment Outcome , Young Adult
6.
Arch Facial Plast Surg ; 1(2): 101-4, 1999.
Article in English | MEDLINE | ID: mdl-10937086

ABSTRACT

BACKGROUND: Pedicled flaps based on the posterior auricular artery have been used for small auricular and mastoid cavity defects. OBJECTIVE: To precisely define the vascular anatomy and angiosome (cutaneous distribution) of the posterior auricular artery. METHODS: A fresh cadaver model was used for 3 separate investigations, studying the posterior auricular artery. Intra-arterial ink injections defined the angiosome, and subtraction angiography and latex injection defined the vascular anatomy in relation to bony and soft tissue landmarks. SUBJECTS: Eight fresh cadavers, 6 men and 2 women, were used, varying in age from 58 to 85 years. RESULTS: The posterior auricular artery has a predictable course in the posterior auricular sulcus. The branching pattern over the auricle and temporal bone and the artery's relationship to bony and soft tissue landmarks were consistent. The angiosome includes the anterior and posterior surfaces of the auricle and the periauricular skin superiorly, posteriorly, and inferiorly. CONCLUSIONS: The investigation documented the consistent vascular anatomy and angiosome of the posterior auricular artery. The cutaneous distribution suggests that a large pedicled or island flap based on the posterior auricular artery may be raised safely as a myocutaneous or myofasciocutaneous flap with temporalis fascia and/or periosteum, extending previously published dimensions. Further studies may extend the clinical application to include free flaps based on the posterior auricular artery.


Subject(s)
Carotid Artery, External/anatomy & histology , Aged , Aged, 80 and over , Angiography, Digital Subtraction , Cadaver , Cerebral Angiography , Confidence Intervals , Female , Humans , Male , Middle Aged , Skin/blood supply , Surgical Flaps/blood supply
7.
Mil Med ; 163(11): 792-3, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9819544

ABSTRACT

Naproxen is a commonly used nonsteroidal anti-inflammatory drug (NSAID) whose side effects include tinnitus and transient hearing loss. Sudden sensorineural hearing loss has rarely been reported as a result of NSAID use. This usually occurs in patients taking other ototoxic medications, with poor renal function, or with autoimmune disease. This article reports the case of an otherwise healthy patient who experienced permanent sensorineural hearing loss after a brief course of naproxen and reviews the literature on NSAID-related permanent sensorineural hearing loss.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Hearing Loss, Sensorineural/chemically induced , Naproxen/adverse effects , Tinnitus/chemically induced , Adult , Anti-Inflammatory Agents/therapeutic use , Female , Hearing Loss, Sensorineural/diagnosis , Hearing Loss, Sensorineural/drug therapy , Humans , Military Personnel , Prednisone/therapeutic use , Tinnitus/diagnosis , Tinnitus/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...